Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.
NYS Entity Status
NYS Filing Date
AUGUST 05, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - CNS PHARMACEUTICALS, INC.
AROUND THE WEB
- A Drug Maker Spends Big in Washington to Make Itself Heard
By JAY HANCOCK, ELIZABETH LUCAS and SYDNEY LUPKIN - Friday Jul 21, 2017
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- Considering the Side Effects of Drugmakers’ Money-Back Guarantees
By KATIE THOMAS and CHARLES ORNSTEIN - Monday Jul 10, 2017
The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.
- Amid Opioid Crisis, Insurers Restrict Pricey, Less Addictive Painkillers
By KATIE THOMAS and CHARLES ORNSTEIN - Monday Sep 18, 2017
Drug companies and doctors have been accused of fueling the opioid crisis, but some question whether insurers have played a role, too.
- Martin Shkreli, ‘Pharma Bro,’ Prepares for Trial: ‘I’m So Innocent’
By STEPHANIE CLIFFORD - Thursday Jun 22, 2017
The former hedge fund manager, vilified by the public and politicians after increasing the price of a prescription drug, is facing eight counts of securities and wire fraud.